GlobalData on MSN18h
Ensho Therapeutics reveals data of NSHO-101 for inflammatory bowel disease
Ensho Therapeutics has presented additional data supporting NSHO-101, also referred to as EA1080, as an oral one-time-a-day ...
Gastric Cancer Global Market Report 2025: Impressive Global Market Trends And Leading Industry Players In Oncology
The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
manilatimes20h
Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients
Allarity expects to pursue multiple advantaged regulatory pathways to expedite approval in the first half of 2025. Allarity ...
Compass Therapeutics: Good Execution, Major Catalysts Ahead
Compass Therapeutics' lead candidate, tovecimig, shows mixed data in various trials, with a significant upcoming phase 3 ...
BlackDoctor14h
Health Equity is Profitable—So Why Isn’t It a Priority?
The discussion ended with a bold call to action for businesses, healthcare providers, and policymakers: health equity must be a priority—not just ethically, but economically. As Burgess put it: “This ...